Integrated Investment Consultants’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,068
Closed -$203K 186
2018
Q2
$203K Hold
2,068
0.11% 154
2018
Q1
$230K Buy
+2,068
New +$232K 0.09% 159
2017
Q3
$194K Hold
2,063
0.08% 164
2017
Q2
$161K Hold
2,063
0.07% 196
2017
Q1
$165K Hold
2,063
0.08% 183
2016
Q4
$162K Buy
2,063
+30
+1% +$2.33K 0.08% 177
2016
Q3
$153K Buy
2,033
+41
+2% +$2.97K 0.08% 179
2016
Q2
$137K Sell
1,992
-2,454
-55% -$169K 0.08% 195
2016
Q1
$310K Hold
4,446
0.18% 85
2015
Q4
$260K Buy
+4,446
New +$271K 0.2% 87

Other funds holding CMD

Integrated Investment Consultants's CMD Position: Q3 2018 in Review

Integrated Investment Consultants sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 2,068 shares — an estimated $203K sold.

Integrated Investment Consultants first reported a position in CMD in Q4 2015 and held it in 10 quarters. The position peaked at $310K in Q1 2016. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • Integrated Investment Consultants reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • Integrated Investment Consultants sold 2,068 Cantel Medical Corporation shares in Q3 2018, an estimated $203K.
  • Integrated Investment Consultants first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 10 quarters.
  • Integrated Investment Consultants's Cantel Medical Corporation position peaked at $310K in Q1 2016.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Integrated Investment Consultants's 13F filing for Q3 2018, filed 29 Oct 2018.